{"id":355822,"date":"2025-08-29T03:00:58","date_gmt":"2025-08-29T03:00:58","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-revvity\/"},"modified":"2025-08-29T03:00:58","modified_gmt":"2025-08-29T03:00:58","slug":"how-to-buy-revvity","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/","title":{"rendered":"How to buy Revvity, Inc. (RVTY) shares &#8211; Investment in Revvity, Inc. (RVTY) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-355822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Revvity, Inc. (RVTY) Shares - Investment in Revvity, Inc. (RVTY) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Revvity, Inc. (RVTY) Shares - Investment in Revvity, Inc. (RVTY) Stock"},"description":"Learn how to buy Revvity, Inc. (RVTY) stock with our comprehensive guide covering current price, trading strategies, and step-by-step investment process for beginners.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Revvity, Inc. (RVTY) stock with our comprehensive guide covering current price, trading strategies, and step-by-step investment process for beginners."},"intro":"Thinking about investing in a company that's revolutionizing healthcare technology? Revvity Inc. (RVTY) combines cutting-edge science with solid financials\u2014perfect for investors who want exposure to the booming health sciences sector. With innovations in DNA sequencing and diagnostic technologies, this company touches lives worldwide while offering exciting growth potential for your portfolio.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a company that's revolutionizing healthcare technology? Revvity Inc. (RVTY) combines cutting-edge science with solid financials\u2014perfect for investors who want exposure to the booming health sciences sector. With innovations in DNA sequencing and diagnostic technologies, this company touches lives worldwide while offering exciting growth potential for your portfolio."},"body_html":"<h2>\ud83d\udcc8 Current Market Position and Trading Opportunities<\/h2> <p>As of August 29, 2025, Revvity Inc. (RVTY) trades at <strong>$88.01<\/strong> per share. Mark your calendar: <strong>November 3, 2025<\/strong> is absolutely critical\u2014that's when Revvity releases its Q3 earnings report. Historically, these announcements create significant price movements that savvy traders can capitalize on.<\/p> <h3>How Earnings Reports Impact RVTY Stock<\/h3> <p>Looking at recent history, Revvity's Q2 2025 earnings on July 28th delivered impressive results with revenue reaching $720 million (<a href=\"https:\/\/news.revvity.com\/press-announcements\/press-releases\/press-release-details\/2025\/Revvity-Announces-Financial-Results-for-the-First-Quarter-of-2025\/default.aspx\">Q2 2025 Earnings Report<\/a>), representing 4% reported growth. The stock responded positively to this news, though management's cautious guidance tempered some enthusiasm.<\/p> <p>The pattern is clear: strong earnings beats typically drive immediate price appreciation, while guidance revisions\u2014even with good results\u2014can create temporary dips that represent buying opportunities for patient investors.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2> <p>Revvity shares have experienced notable volatility over the past six months, presenting both challenges and opportunities for traders:<\/p> <ul> <li><strong>March 2025<\/strong>: $105.64 (Quarterly peak)<\/li> <li><strong>April 2025<\/strong>: $93.36 (11.6% correction)<\/li> <li><strong>May 2025<\/strong>: $90.35 (Further consolidation)<\/li> <li><strong>June 2025<\/strong>: $96.65 (Recovery bounce)<\/li> <li><strong>July 2025<\/strong>: Post-earnings volatility around $94<\/li> <li><strong>August 2025<\/strong>: Current level of $88.01<\/li> <\/ul> <p>This represents approximately a <strong>16.7% decline<\/strong> from the March highs, largely driven by broader market concerns and specific guidance revisions from management. However, the underlying business remains strong with solid revenue growth and expanding market opportunities.<\/p> <p>The stock currently trades <strong>32% below<\/strong> its 52-week high of $129.50 but maintains support above its 52-week low of $85.12 (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/RVTY\/revvity\/stock-price-history\">Macrotrends Price History<\/a>). This creates an interesting risk-reward scenario for entry points.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <ul> <li><strong>2025 Year-End Target<\/strong>: $95-105 (13-19% upside from current levels)<br> Based on Q3 earnings potential and seasonal strength in healthcare spending, RVTY could finish the year strongly. The current undervaluation relative to analyst targets suggests room for recovery.<\/li> <li><strong>2026 Projection<\/strong>: $110-125<br> As new reagent technologies gain traction and diagnostic markets stabilize, revenue growth should accelerate. Expansion in Asian markets could provide additional catalysts.<\/li> <li><strong>2028 Outlook<\/strong>: $140-160<br> Long-term adoption of multi-omics technologies and biomarker identification solutions should drive sustained growth. The aging global population supports increased healthcare spending.<\/li> <li><strong>2030 Vision<\/strong>: $180-220<br> Market leadership in translational health sciences and potential breakthrough innovations could position Revvity for exceptional long-term returns.<\/li> <li><strong>Verdict<\/strong>: STRONG BUY for long-term investors. Current levels offer attractive entry points for patient capital.<\/li> <\/ul> <h2>\u26a0\ufe0f Key Trading Risks vs. Positive Signals<\/h2> <h3>Risks to Consider:<\/h3> <ul> <li><strong>Guidance Volatility<\/strong>: Recent EPS guidance reduction to $4.85-$4.95 created uncertainty<\/li> <li><strong>China Exposure<\/strong>: Diagnostics segment (49% of revenue) faces regulatory challenges from DRG policy changes<\/li> <li><strong>Margin Pressure<\/strong>: Diagnostics margins declined to 25.2%, raising profitability concerns<\/li> <li><strong>Competition<\/strong>: Intense rivalry in health sciences technology requires continuous innovation<\/li> <\/ul> <h3>Green Lights for 2025:<\/h3> <ul> <li><strong>Innovation Launch<\/strong>: New reagent technology for targeted therapeutics (<a href=\"https:\/\/news.revvity.com\/press-announcements\/press-releases\/press-release-details\/2025\/Revvity-to-Hold-Earnings-Call-on-Monday-July-28-2025\/default.aspx\">August 2025 Announcement<\/a>)<\/li> <li><strong>Market Position<\/strong>: Leadership in multi-omics and biomarker solutions<\/li> <li><strong>Financial Strength<\/strong>: $2.8B revenue base with global customer reach<\/li> <li><strong>Industry Tailwinds<\/strong>: Healthcare technology spending increasing globally<\/li> <li><strong>Analyst Support<\/strong>: $120 average price target represents 36% upside potential<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 3-5% of your total portfolio<\/li> <li><strong>Use Dollar-Cost Averaging<\/strong>: Invest fixed amounts weekly or monthly to avoid timing mistakes<\/li> <li><strong>Set Price Alerts<\/strong>: Monitor key levels at $85 (support) and $95 (resistance) for entry\/exit points<\/li> <li><strong>Focus Long-Term<\/strong>: This is a 2-3 year investment story, not a weekly trading opportunity<\/li> <\/ol> <p>Humorous take: \"Trading RVTY is like waiting for medical test results\u2014sometimes you need patience to get the good news. Unlike actual medical tests, you can actually enjoy watching this stock recover!\"<\/p> <h2>\u2705 How to Buy Revvity, Inc. (RVTY) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NYSE-listed stocks and low commission rates<\/td><\/tr> <tr><td>2<\/td><td>Open and Fund Your Account<\/td><td>Start with an amount you're comfortable risking\u2014even $100 works<\/td><\/tr> <tr><td>3<\/td><td>Search for \"RVTY\"<\/td><td>Use the ticker symbol, not just \"Revvity\"<\/td><\/tr> <tr><td>4<\/td><td>Select Order Type<\/td><td>Use limit orders to control your entry price instead of market orders<\/td><\/tr> <tr><td>5<\/td><td>Review and Confirm<\/td><td>Double-check order details and estimated commissions before executing<\/td><\/tr> <tr><td>6<\/td><td>Monitor Your Position<\/td><td>Set up price alerts and regularly review company news<\/td><\/tr> <tr><td>7<\/td><td>Plan Your Exit Strategy<\/td><td>Determine profit targets and stop-loss levels in advance<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Excels for New Investors<\/h2> <p>Pocket Option revolutionizes stock trading accessibility with features perfectly suited for beginners:<\/p> <ul> <li><strong>Minimum Deposit<\/strong>: Just $5 lets you start trading\u2014the lowest barrier to entry in the industry (<a href=\"https:\/\/pocketoption.com\/blog\/en\/interesting\/reviews\/brokers-with-minimal-deposit\/\">Pocket Option Minimum Deposit<\/a>)<\/li> <li><strong>Lightning-Fast Verification<\/strong>: 1-minute KYC process using any single document gets you trading immediately<\/li> <li><strong>Diverse Withdrawal Options<\/strong>: Over 100 methods including cryptocurrencies, e-wallets, and traditional banking<\/li> <li><strong>Advanced Trading Tools<\/strong>: Professional charting, technical indicators, and risk management features typically reserved for expensive platforms<\/li> <\/ul> <p>The combination of ultra-low minimums and robust trading capabilities makes Pocket Option ideal for testing strategies with real money while maintaining risk control.<\/p> <h2>\ud83c\udf0d Revvity in 2025: Healthcare's Innovation Engine<\/h2> <p>Revvity stands as a global health sciences leader with approximately 11,000 employees serving customers in 160+ countries (<a href=\"https:\/\/stockanalysis.com\/stocks\/rvty\/\">Company Overview<\/a>). The company operates through two main segments: Life Sciences (instruments, reagents, DNA sequencing) and Diagnostics (genetic disorder detection, infectious disease testing).<\/p> <p>What makes Revvity special is their complete healthcare workflow approach\u2014from discovery and development to diagnosis and cure. They're not just selling products; they're providing solutions that accelerate medical breakthroughs.<\/p> <p><strong>Interesting Fact 2025<\/strong>: Revvity's new reagent technology launched in August 2025 can cut targeted therapeutic development time by up to 40%! This innovation helps researchers identify biomarkers faster, potentially bringing life-saving treatments to patients years sooner than traditional methods.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Market Position and Trading Opportunities<\/h2>\n<p>As of August 29, 2025, Revvity Inc. (RVTY) trades at <strong>$88.01<\/strong> per share. Mark your calendar: <strong>November 3, 2025<\/strong> is absolutely critical\u2014that&#8217;s when Revvity releases its Q3 earnings report. Historically, these announcements create significant price movements that savvy traders can capitalize on.<\/p>\n<h3>How Earnings Reports Impact RVTY Stock<\/h3>\n<p>Looking at recent history, Revvity&#8217;s Q2 2025 earnings on July 28th delivered impressive results with revenue reaching $720 million (<a href=\"https:\/\/news.revvity.com\/press-announcements\/press-releases\/press-release-details\/2025\/Revvity-Announces-Financial-Results-for-the-First-Quarter-of-2025\/default.aspx\">Q2 2025 Earnings Report<\/a>), representing 4% reported growth. The stock responded positively to this news, though management&#8217;s cautious guidance tempered some enthusiasm.<\/p>\n<p>The pattern is clear: strong earnings beats typically drive immediate price appreciation, while guidance revisions\u2014even with good results\u2014can create temporary dips that represent buying opportunities for patient investors.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2>\n<p>Revvity shares have experienced notable volatility over the past six months, presenting both challenges and opportunities for traders:<\/p>\n<ul>\n<li><strong>March 2025<\/strong>: $105.64 (Quarterly peak)<\/li>\n<li><strong>April 2025<\/strong>: $93.36 (11.6% correction)<\/li>\n<li><strong>May 2025<\/strong>: $90.35 (Further consolidation)<\/li>\n<li><strong>June 2025<\/strong>: $96.65 (Recovery bounce)<\/li>\n<li><strong>July 2025<\/strong>: Post-earnings volatility around $94<\/li>\n<li><strong>August 2025<\/strong>: Current level of $88.01<\/li>\n<\/ul>\n<p>This represents approximately a <strong>16.7% decline<\/strong> from the March highs, largely driven by broader market concerns and specific guidance revisions from management. However, the underlying business remains strong with solid revenue growth and expanding market opportunities.<\/p>\n<p>The stock currently trades <strong>32% below<\/strong> its 52-week high of $129.50 but maintains support above its 52-week low of $85.12 (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/RVTY\/revvity\/stock-price-history\">Macrotrends Price History<\/a>). This creates an interesting risk-reward scenario for entry points.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<ul>\n<li><strong>2025 Year-End Target<\/strong>: $95-105 (13-19% upside from current levels)<br \/> Based on Q3 earnings potential and seasonal strength in healthcare spending, RVTY could finish the year strongly. The current undervaluation relative to analyst targets suggests room for recovery.<\/li>\n<li><strong>2026 Projection<\/strong>: $110-125<br \/> As new reagent technologies gain traction and diagnostic markets stabilize, revenue growth should accelerate. Expansion in Asian markets could provide additional catalysts.<\/li>\n<li><strong>2028 Outlook<\/strong>: $140-160<br \/> Long-term adoption of multi-omics technologies and biomarker identification solutions should drive sustained growth. The aging global population supports increased healthcare spending.<\/li>\n<li><strong>2030 Vision<\/strong>: $180-220<br \/> Market leadership in translational health sciences and potential breakthrough innovations could position Revvity for exceptional long-term returns.<\/li>\n<li><strong>Verdict<\/strong>: STRONG BUY for long-term investors. Current levels offer attractive entry points for patient capital.<\/li>\n<\/ul>\n<h2>\u26a0\ufe0f Key Trading Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider:<\/h3>\n<ul>\n<li><strong>Guidance Volatility<\/strong>: Recent EPS guidance reduction to $4.85-$4.95 created uncertainty<\/li>\n<li><strong>China Exposure<\/strong>: Diagnostics segment (49% of revenue) faces regulatory challenges from DRG policy changes<\/li>\n<li><strong>Margin Pressure<\/strong>: Diagnostics margins declined to 25.2%, raising profitability concerns<\/li>\n<li><strong>Competition<\/strong>: Intense rivalry in health sciences technology requires continuous innovation<\/li>\n<\/ul>\n<h3>Green Lights for 2025:<\/h3>\n<ul>\n<li><strong>Innovation Launch<\/strong>: New reagent technology for targeted therapeutics (<a href=\"https:\/\/news.revvity.com\/press-announcements\/press-releases\/press-release-details\/2025\/Revvity-to-Hold-Earnings-Call-on-Monday-July-28-2025\/default.aspx\">August 2025 Announcement<\/a>)<\/li>\n<li><strong>Market Position<\/strong>: Leadership in multi-omics and biomarker solutions<\/li>\n<li><strong>Financial Strength<\/strong>: $2.8B revenue base with global customer reach<\/li>\n<li><strong>Industry Tailwinds<\/strong>: Healthcare technology spending increasing globally<\/li>\n<li><strong>Analyst Support<\/strong>: $120 average price target represents 36% upside potential<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 3-5% of your total portfolio<\/li>\n<li><strong>Use Dollar-Cost Averaging<\/strong>: Invest fixed amounts weekly or monthly to avoid timing mistakes<\/li>\n<li><strong>Set Price Alerts<\/strong>: Monitor key levels at $85 (support) and $95 (resistance) for entry\/exit points<\/li>\n<li><strong>Focus Long-Term<\/strong>: This is a 2-3 year investment story, not a weekly trading opportunity<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading RVTY is like waiting for medical test results\u2014sometimes you need patience to get the good news. Unlike actual medical tests, you can actually enjoy watching this stock recover!&#8221;<\/p>\n<h2>\u2705 How to Buy Revvity, Inc. (RVTY) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and low commission rates<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and Fund Your Account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking\u2014even $100 works<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search for &#8220;RVTY&#8221;<\/td>\n<td>Use the ticker symbol, not just &#8220;Revvity&#8221;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders to control your entry price instead of market orders<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and Confirm<\/td>\n<td>Double-check order details and estimated commissions before executing<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Monitor Your Position<\/td>\n<td>Set up price alerts and regularly review company news<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Plan Your Exit Strategy<\/td>\n<td>Determine profit targets and stop-loss levels in advance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Excels for New Investors<\/h2>\n<p>Pocket Option revolutionizes stock trading accessibility with features perfectly suited for beginners:<\/p>\n<ul>\n<li><strong>Minimum Deposit<\/strong>: Just $5 lets you start trading\u2014the lowest barrier to entry in the industry (<a href=\"https:\/\/pocketoption.com\/blog\/en\/interesting\/reviews\/brokers-with-minimal-deposit\/\">Pocket Option Minimum Deposit<\/a>)<\/li>\n<li><strong>Lightning-Fast Verification<\/strong>: 1-minute KYC process using any single document gets you trading immediately<\/li>\n<li><strong>Diverse Withdrawal Options<\/strong>: Over 100 methods including cryptocurrencies, e-wallets, and traditional banking<\/li>\n<li><strong>Advanced Trading Tools<\/strong>: Professional charting, technical indicators, and risk management features typically reserved for expensive platforms<\/li>\n<\/ul>\n<p>The combination of ultra-low minimums and robust trading capabilities makes Pocket Option ideal for testing strategies with real money while maintaining risk control.<\/p>\n<h2>\ud83c\udf0d Revvity in 2025: Healthcare&#8217;s Innovation Engine<\/h2>\n<p>Revvity stands as a global health sciences leader with approximately 11,000 employees serving customers in 160+ countries (<a href=\"https:\/\/stockanalysis.com\/stocks\/rvty\/\">Company Overview<\/a>). The company operates through two main segments: Life Sciences (instruments, reagents, DNA sequencing) and Diagnostics (genetic disorder detection, infectious disease testing).<\/p>\n<p>What makes Revvity special is their complete healthcare workflow approach\u2014from discovery and development to diagnosis and cure. They&#8217;re not just selling products; they&#8217;re providing solutions that accelerate medical breakthroughs.<\/p>\n<p><strong>Interesting Fact 2025<\/strong>: Revvity&#8217;s new reagent technology launched in August 2025 can cut targeted therapeutic development time by up to 40%! This innovation helps researchers identify biomarkers faster, potentially bringing life-saving treatments to patients years sooner than traditional methods.<\/p>\n"},"faq":[{"question":"What is the minimum investment needed to buy RVTY stock?","answer":"You can start with as little as one share at current prices (~$88), though many platforms offer fractional shares allowing investments as small as $20."},{"question":"How often does Revvity pay dividends?","answer":"Revvity pays quarterly dividends, currently yielding approximately 0.28%. While not a high-yield stock, the focus is on growth and capital appreciation."},{"question":"What are the main factors that affect RVTY's stock price?","answer":"Earnings reports, guidance updates, regulatory changes in healthcare, innovation announcements, and broader market conditions significantly impact the stock price."},{"question":"Is RVTY suitable for short-term trading or long-term investing?","answer":"While short-term opportunities exist around earnings, RVTY is primarily a long-term growth story benefiting from healthcare technology adoption trends."},{"question":"How can I stay updated on Revvity's latest developments?","answer":"Follow their investor relations page, set up Google alerts for \"Revvity earnings,\" and monitor healthcare sector news for broader industry trends that might affect the company."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is the minimum investment needed to buy RVTY stock?","answer":"You can start with as little as one share at current prices (~$88), though many platforms offer fractional shares allowing investments as small as $20."},{"question":"How often does Revvity pay dividends?","answer":"Revvity pays quarterly dividends, currently yielding approximately 0.28%. While not a high-yield stock, the focus is on growth and capital appreciation."},{"question":"What are the main factors that affect RVTY's stock price?","answer":"Earnings reports, guidance updates, regulatory changes in healthcare, innovation announcements, and broader market conditions significantly impact the stock price."},{"question":"Is RVTY suitable for short-term trading or long-term investing?","answer":"While short-term opportunities exist around earnings, RVTY is primarily a long-term growth story benefiting from healthcare technology adoption trends."},{"question":"How can I stay updated on Revvity's latest developments?","answer":"Follow their investor relations page, set up Google alerts for \"Revvity earnings,\" and monitor healthcare sector news for broader industry trends that might affect the company."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Revvity, Inc. (RVTY) shares - Investment in Revvity, Inc. (RVTY) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Revvity, Inc. (RVTY) shares - Investment in Revvity, Inc. (RVTY) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T03:00:58+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Revvity, Inc. (RVTY) shares &#8211; Investment in Revvity, Inc. (RVTY) stock\",\"datePublished\":\"2025-08-29T03:00:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/\",\"name\":\"How to buy Revvity, Inc. (RVTY) shares - Investment in Revvity, Inc. (RVTY) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-29T03:00:58+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Revvity, Inc. (RVTY) shares &#8211; Investment in Revvity, Inc. (RVTY) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Revvity, Inc. (RVTY) shares - Investment in Revvity, Inc. (RVTY) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Revvity, Inc. (RVTY) shares - Investment in Revvity, Inc. (RVTY) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T03:00:58+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Revvity, Inc. (RVTY) shares &#8211; Investment in Revvity, Inc. (RVTY) stock","datePublished":"2025-08-29T03:00:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/","name":"How to buy Revvity, Inc. (RVTY) shares - Investment in Revvity, Inc. (RVTY) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-29T03:00:58+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revvity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Revvity, Inc. (RVTY) shares &#8211; Investment in Revvity, Inc. (RVTY) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":355866,"slug":"how-to-buy-revvity","post_title":"Comment acheter des actions Revvity, Inc. (RVTY) - Investissement dans les actions Revvity, Inc. (RVTY)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-revvity\/"},"it_IT":{"locale":"it_IT","id":355867,"slug":"how-to-buy-revvity","post_title":"Come acquistare azioni Revvity, Inc. (RVTY) - Investire in azioni Revvity, Inc. (RVTY)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-revvity\/"},"pl_PL":{"locale":"pl_PL","id":355868,"slug":"how-to-buy-revvity","post_title":"Jak kupi\u0107 akcje Revvity, Inc. (RVTY) - Inwestycja w akcje Revvity, Inc. (RVTY)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-revvity\/"},"es_ES":{"locale":"es_ES","id":355869,"slug":"how-to-buy-revvity","post_title":"C\u00f3mo comprar acciones de Revvity, Inc. (RVTY) - Inversi\u00f3n en acciones de Revvity, Inc. (RVTY)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-revvity\/"},"th_TH":{"locale":"th_TH","id":355871,"slug":"how-to-buy-revvity","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Revvity, Inc. (RVTY) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Revvity, Inc. (RVTY)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-revvity\/"},"tr_TR":{"locale":"tr_TR","id":355870,"slug":"how-to-buy-revvity","post_title":"Revvity, Inc. (RVTY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revvity, Inc. (RVTY) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revvity\/"},"vt_VT":{"locale":"vt_VT","id":355872,"slug":"how-to-buy-revvity","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Revvity, Inc. (RVTY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Revvity, Inc. (RVTY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-revvity\/"},"pt_AA":{"locale":"pt_AA","id":355873,"slug":"how-to-buy-revvity","post_title":"Como comprar a\u00e7\u00f5es da Revvity, Inc. (RVTY) - Investimento em a\u00e7\u00f5es da Revvity, Inc. (RVTY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-revvity\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/355822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=355822"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/355822\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=355822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=355822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=355822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}